BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17094038)

  • 1. Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children.
    Ward MJ; Pauliny J; Lipper EG; Bussel JB
    Am J Perinatol; 2006 Nov; 23(8):487-92. PubMed ID: 17094038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal treatment of alloimmune thrombocytopenia.
    Lynch L; Bussel JB; McFarland JG; Chitkara U; Berkowitz RL
    Obstet Gynecol; 1992 Jul; 80(1):67-71. PubMed ID: 1603500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow up of children after antenatal treatment for alloimmune thrombocytopenia.
    Radder CM; de Haan MJ; Brand A; Stoelhorst GM; Veen S; Kanhai HH
    Early Hum Dev; 2004 Oct; 80(1):65-76. PubMed ID: 15363839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates.
    Bussel JB; Primiani A
    Blood Rev; 2008 Jan; 22(1):33-52. PubMed ID: 17981381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal treatment of neonatal alloimmune thrombocytopenia.
    Bussel JB; Berkowitz RL; McFarland JG; Lynch L; Chitkara U
    N Engl J Med; 1988 Nov; 319(21):1374-8. PubMed ID: 3141811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital posthemorrhagic hydrocephalus: a case of fetomaternal alloimmune thrombocytopenia.
    Póvoa AM; Ramalho C; Machado AP; Matias A; Montenegro N
    Fetal Diagn Ther; 2007; 22(5):321-4. PubMed ID: 17556816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal alloimmune thrombocytopenia.
    Bussel JB; Zabusky MR; Berkowitz RL; McFarland JG
    N Engl J Med; 1997 Jul; 337(1):22-6. PubMed ID: 9203427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
    Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
    Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.
    Berkowitz RL; Lesser ML; McFarland JG; Wissert M; Primiani A; Hung C; Bussel JB
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):249-55. PubMed ID: 17666597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of feto-maternal alloimmune thrombocytopenia: report of three cases.
    Paternoster DM; Cester M; Memmo A; Scandellari R; Fabris F; Girolami A
    J Matern Fetal Neonatal Med; 2006 Aug; 19(8):517-20. PubMed ID: 16966118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
    Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
    Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prenatal management of fetuses with alloimmune thrombocytopenia].
    Kroll H; Kiefel V; Giers G; Kaplan C; Murphy M; Waters A; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1996; 33():150-5. PubMed ID: 8974688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.
    Bussel JB; Zacharoulis S; Kramer K; McFarland JG; Pauliny J; Kaplan C
    Pediatr Blood Cancer; 2005 Aug; 45(2):176-83. PubMed ID: 15828027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloimmune thrombocytopenia of the fetus and the newborn.
    Kaplan C
    Blood Rev; 2002 Mar; 16(1):69-72. PubMed ID: 11914000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia.
    Radder CM; Brand A; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):683-8. PubMed ID: 11568798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic thrombocytopenic purpura in pregnancy: a single institutional experience with maternal and neonatal outcomes.
    Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Bülbül-Başkan E; Develioğlu O; Tüfekçi M; Tunali A
    Ann Hematol; 2003 Jun; 82(6):348-52. PubMed ID: 12734677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia.
    Thung SF; Grobman WA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1094-9. PubMed ID: 16157118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
    Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is a non-invasive management allowed for maternofetal alloimmune thrombocytopenia? Experience over a 10-year period].
    Deruelle P; Wibaut B; Manessier L; Subtil D; Vaast P; Puech F; Valat AS
    Gynecol Obstet Fertil; 2007 Mar; 35(3):199-204. PubMed ID: 17306591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.